MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BioCryst Pharmaceuticals Company Profile (NASDAQ:BCRX)

Consensus Ratings for BioCryst Pharmaceuticals (NASDAQ:BCRX) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $17.00 (9.82% upside)

Current Analysts' Coverage Summary for BioCryst Pharmaceuticals (NASDAQ:BCRX)
Show:
DateFirmActionRatingPrice TargetActions
6/30/2015Bank of AmericaUpgradeNeutral -> Buy$12.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015OppenheimerReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015FBR & Co.Initiated CoverageOutperform$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Needham & Company LLCSet Price TargetBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014MLV & Co.Set Price TargetBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014Noble FinancialReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014JPMorgan Chase & Co.Lower Price TargetOverweight$20.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2014Wells Fargo & Co.UpgradeMarket Perform -> Outperform$19.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/30/2014HC WainwrightBoost Price TargetBuy$21.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2014Roth CapitalBoost Price Target$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2014Brinson PatrickInitiated CoverageOutperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014Piper JaffrayInitiated CoverageOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014MizuhoInitiated CoverageBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2014JMP SecuritiesReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha